@clellandlab.bsky.social
The Clelland lab is devoted to curing neurodegenerative diseases. We are working to create therapies for patients with fatal FTD, ALS, AD, PD and other neurologic diseases
We weigh risks vs. benefits in fatal diseases—waiting for perfection shouldn’t delay life-saving therapies. Our framework guides research on CRISPR off-targets and clinical decisions.
Congrats to Ariella Angelini Stewart on her first, first-author publication!
www.nature.com/articles/s41...
Congrats to Ariella Angelini Stewart on her first, first-author publication!
www.nature.com/articles/s41...
December 2, 2025 at 7:13 PM
We weigh risks vs. benefits in fatal diseases—waiting for perfection shouldn’t delay life-saving therapies. Our framework guides research on CRISPR off-targets and clinical decisions.
Congrats to Ariella Angelini Stewart on her first, first-author publication!
www.nature.com/articles/s41...
Congrats to Ariella Angelini Stewart on her first, first-author publication!
www.nature.com/articles/s41...